Category Archives: Molecular Cardiology

Invicro LLC, a Konica Minolta company announces that the paper "Synaptic Density Marker SV2A is Reduced in Schizophrenia Patients and Unaffected by Antipsychotics in Rats1" has been published in Nature Communications. Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug discovery and development. Continue reading →

Increasing cases of diseases such as cancer, and orthopedic disorders are likely to propel growth of the medical imaging equipment market says Fortune Business Insights in a published report, titled Medical Imaging Equipment Market Size, Share and Global Trend by Type (Magnetic Resonance Imaging Equipment, Computed Tomography Equipment, X-ray Equipment, Ultrasound Equipment Molecular Imaging Equipment), By Application (Cardiology, Neurology, Orthopedics, Gynecology, Oncology), By End-User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Others) and Geography Forecast till 2026.As per the report, the market is projected to reach a value of US$ 44,077.7 Mn at a CAGR of 4.6% by 2025 from US$ 30,814.2 Mn in 2017. The report covers: Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/medical-imaging-equipment-market-100382 Leading Players operating in the Medical Imaging Equipment Market are: Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Continue reading →

NEW YORK (PRWEB) January 16, 2020 Many liver cancer tumors contain a highly diverse set of cells, a phenomenon known as intra-tumor heterogeneity that can significantly affect the rate at which the cancer grows, Mount Sinai researchers report. The immune systems contribution to this heterogeneity can have major clinical implications. Continue reading →

About 15 years ago, an Amish family in the eastern US was hit by an unexplainable tragedy -- one of their children died suddenly while playing and running around. Just a few months later, the same fate befell another one of their children. Six years later, they lost another child. Continue reading →

PARIS and NEW YORK, Jan. 15, 2020 (GLOBE NEWSWIRE) -- QuantumGenomics (EuronextGrowth - FR0011648971 - ALQGC, OTCQX - QNNTF), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat resistant hypertension and heart failure, today announced it will share preclinical results of firibastat in heart failure post myocardial ischemia during an oral presentation at the Gordon Research Conference being held from February 8-14, 2020 in Barga, Italy Continue reading →

CHICAGO, Jan. 16, 2020 /PRNewswire/ -- According to the new market research report "Isothermal Nucleic Acid Amplification Technology Marketby Product (Assay & Kit, System), Application (Infectious disease [HIV, Influenza], Blood Screening), Type (LAMP, SDA, NASBA, HDA), End User, Region - Global Forecast to 2024", published by MarketsandMarkets, the global INAAT Market size is expected to grow from USD 1.9 billion in 2019 to USD 3.3 billion by 2024, at a CAGR of 11.0% during the forecast period Continue reading →

LONDON--(BUSINESS WIRE)--The global nuclear imaging equipment market is poised to grow by USD 858.76 million during 2019-2023, progressing at a CAGR of over 6% during the forecast period. Continue reading →

Shifts from small to seismic rocked the practice of cardiology in 2019, impacting physicians across subspecialties. Whats fortunateand perhaps instrumental in these changesis that it was a really good year [for professional] societies being united in the face of uncertainty or obstacles, Richard Kovacs, MD (Indiana University School of Medicine, Indianapolis), president of the American College of Cardiology (ACC), told TCTMD. Continue reading →

In a first, researchers, including one of Indian-origin, have reprogrammed the human bodys fat cells into those similar to the hearts pacemaker cells which control heartbeat by creating rhythmic electrical impulses -- an advance that may lead to new therapies for cardiac failure. Continue reading →

NEW DELHI: In a first, researchers, including one of Indianorigin, have reprogrammed the human bodys fat cells into those similar to the hearts pacemaker cells which control heartbeat by creating rhythmic electrical impulses an advance that may lead to new therapies for cardiac failure. The study, published in the Journal of Molecular and Cellular Cardiology, noted that the new pacemaker-like cell may become a useful alternative treatment for heart conduction system disorders, and to bridge the limitations of current treatments such as artificial pacemakers Continue reading →